English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | May 10, 2024

Mayo study: Race, sex influence melanoma detection and outcomes
+ Pharmaceuticals
Patient Daily | May 9, 2024

Exploring the link between hearing loss and dementia
+ Pharmaceuticals
Patient Daily | May 9, 2024

AI model developed to understand link between brain activity and illness
+ Pharmaceuticals
Patient Daily | May 9, 2024

TRISH announces first selection for Space Health Ingress Program solicitation
+ Pharmaceuticals
Patient Daily | May 8, 2024

American Lung Association Recognized for Innovative Work to Help People with Advanced Lung Disease
+ Pharmaceuticals
Patient Daily | May 8, 2024

Connecticut suspends funds for Tobacco and Health Trust Fund: American Lung Association reacts
+ Pharmaceuticals
Patient Daily | May 8, 2024

McGovern Medical School professor shapes future doctors through mentoring
+ Pharmaceuticals
Patient Daily | May 7, 2024

American Lung Association Marks 10 Years of Progress in Ending Lung Cancer

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes